[go: up one dir, main page]

HUP9903165A3 - Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders - Google Patents

Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders

Info

Publication number
HUP9903165A3
HUP9903165A3 HU9903165A HUP9903165A HUP9903165A3 HU P9903165 A3 HUP9903165 A3 HU P9903165A3 HU 9903165 A HU9903165 A HU 9903165A HU P9903165 A HUP9903165 A HU P9903165A HU P9903165 A3 HUP9903165 A3 HU P9903165A3
Authority
HU
Hungary
Prior art keywords
amosulalol
preparation
pharmaceutical compositions
treating ocular
circulation disorders
Prior art date
Application number
HU9903165A
Other languages
Hungarian (hu)
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Priority to HU9903165A priority Critical patent/HUP9903165A3/en
Publication of HUP9903165A2 publication Critical patent/HUP9903165A2/en
Publication of HUP9903165A3 publication Critical patent/HUP9903165A3/en

Links

HU9903165A 1997-07-25 1997-07-25 Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders HUP9903165A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9903165A HUP9903165A3 (en) 1997-07-25 1997-07-25 Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9903165A HUP9903165A3 (en) 1997-07-25 1997-07-25 Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders

Publications (2)

Publication Number Publication Date
HUP9903165A2 HUP9903165A2 (en) 2000-02-28
HUP9903165A3 true HUP9903165A3 (en) 2000-04-28

Family

ID=89999374

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903165A HUP9903165A3 (en) 1997-07-25 1997-07-25 Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders

Country Status (1)

Country Link
HU (1) HUP9903165A3 (en)

Also Published As

Publication number Publication date
HUP9903165A2 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL121170A0 (en) Compositions for the treatment of dermatological disorders
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
HUP0004412A3 (en) Use of heterocyclic vinylethers for the preparation of pharmaceutical compositions treating neurological disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
HUP0001442A3 (en) Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
HUP9900886A3 (en) Use of bisphosphonates preventing bone loss associated with immunosuppressive therapy for the preparation of pharmaceutical compositions
HUP0200287A3 (en) Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
GB9510162D0 (en) Compositions for the treatment of skin conditions
HUP9903679A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
HUP9903688A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating autism
IL116747A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment of gynaecomastia
AU686084B3 (en) Pharmaceutical compositions for the treatment of depressive disorders
IL121647A0 (en) Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
BR9507732A (en) Pharmaceutical composition for the treatment of glaucoma
HUP9903165A3 (en) Use of amosulalol for the preparation of pharmaceutical compositions treating ocular circulation disorders
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states